Freespira, Inc.
Freespira develops an FDA-cleared digital therapeutic that uses capnometry-guided breathing retraining to reduce or eliminate panic disorder and PTSD symptoms in a 28-day at-home protocol, serving health plans, self-insured employers, the VA, and individual patients.
- Company typePrivate
- Founded2013
- HeadquartersKirkland, United States
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What Freespira, Inc. does
Freespira, Inc. is a privately held digital therapeutics company founded in 2013 and headquartered in Kirkland, Washington. The company has developed the only FDA-cleared digital therapeutic that targets the physiological underpinnings of panic disorder and post-traumatic stress disorder (PTSD) — specifically dysregulated breathing patterns and CO2 hypersensitivity — through capnometry-guided respiratory intervention (CGRI). Its product, now in its fifth-generation hardware form (FST5), pairs a proprietary NDIR CO2 sensor and nasal cannula with a connected tablet providing real-time audio/visual biofeedback, plus dedicated human coaching. Patients complete a structured 28-day protocol of two daily 17-minute sessions, with results showing 73-86% panic-attack-free rates immediately post-treatment and 71-80% sustained reductions at 12 months.
The underlying technology stack combines a medical-grade breathing sensor, embedded firmware, a guided software experience, and a licensed clinical coaching layer. The platform has accumulated three FDA 510(k) clearances (panic disorder K131586 in 2013, PTSD K180173 in 2018, and adolescent expansion K233337 in May 2025), and clinical evidence spans 6,000+ patients across multiple peer-reviewed studies.
Freespira's business model is built on B2B2C distribution with three primary revenue channels: (1) health plan and self-insured employer benefit coverage under multi-year subscription contracts with outcomes-based pricing, including a recently launched "Zero Risk" program offering 1:1 ROI guarantees; (2) VA federal procurement via Lovell Government Services on the Federal Supply Schedule (FSS 65IIA #V797D-50450); and (3) direct-to-consumer self-referral with self-pay, HSA/FSA, or interest-free payment options. Named customers include Highmark BCBS, Point32Health (2.2M members), WellCare of Kentucky Medicaid (450,000 members; 12% estimated eligible), Security Health Plan, Brighton Marine Health Plan, and the VA, collectively covering approximately 40 million lives.
Freespira, Inc. firmographics
Firmographics- Name
- Freespira, Inc.
- Legal name
- Freespira, Inc.
- Website
- https://freespira.com
- Company type
- Private
- Founded year
- 2013
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Freespira develops an FDA-cleared digital therapeutic that uses capnometry-guided breathing retraining to reduce or eliminate panic disorder and PTSD symptoms in a 28-day at-home protocol, serving health plans, self-insured employers, the VA, and individual patients.
- Ownership category
- akta.pro rank
Freespira, Inc. industry classification
Industry- Product category
- Digital Therapeutics
- NAICS
- Home Health Care Services (62161), Home Health Care Services (621610)
- SIC
- Services-Misc Health & Allied Services, Nec (8090), Services-Prepackaged Software (7372)
- akta.pro primary industry
- Connected Therapeutics & Smart Drug Delivery Monitoring (HLACAFAL)
- akta.pro secondary industries
- Medication Adherence, Digital Therapeutics & Remote Coaching (condition-specific programs) (HLALAFAF), Chronic Condition Virtual Care & Disease Management (Payer-Sponsored) (HLALACAE)
Keywords
Where Freespira, Inc. is headquartered
LocationHeadquarters
- HQ city
- Kirkland
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Freespira, Inc. business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure, Supply Chain
Revenue model
- Health Plan and Employer Benefit Coverage: Freespira is covered by health plans and self-insured employers as a medical benefit. Health plans and employers pay per-enrolled member or per-completed-treatment under outcomes-based pricing arrangements. The Zero Risk program offers performance guarantees (1:1 ROI) and outcomes-based pricing.
- VA Federal Procurement: Freespira is listed on the Federal Supply Schedule (65IIA: V797D-50450) through SDVOSB partner Lovell Government Services. VA pays for treatments authorized through VA procurement processes.
- Self-Pay / HSA/FSA / Payment Plans: Patients without insurance coverage can use HSA/FSA accounts or enroll in an interest-free payment plan. Self-pay provides an alternative revenue stream for individual consumers.
- Outcomes-Based / Performance Pricing: The Zero Risk program for health plans ties full payment to clinical outcome benchmarks. Health plans only pay full price for members who achieve defined clinical improvement thresholds.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Multi-year contract | Insurance/Health Plan Covered |
| Subscription | Multi-year contract | VA-Covered Veterans |
| One time/ perpetual license | Pay-as-you-go | Self-Pay / HSA/FSA |
| Outcome Based/ Performance | Annual | Outcomes-Based Pricing (Zero Risk Program) |
Go-to-market motion4 records
Distribution channels5 records
Marketing channels7 records
Freespira, Inc. product offering
Product offeringCore offering
Freespira develops and sells an FDA-cleared at-home digital therapeutic that combines a proprietary breathing sensor, integrated tablet with real-time capnometry feedback software, and Care Specialist coaching to normalize dysfunctional breathing patterns and reduce or eliminate symptoms of panic attacks, panic disorder, and PTSD in a 28-day protocol. The bundled treatment kit is shipped directly to patients' homes and is covered as a medical benefit by health plans, self-insured employers, and the VA.
Product overview
Freespira, Inc. offers a single unified digital therapeutic product—the Freespira system—for the treatment of panic disorder, panic attacks, and PTSD symptoms. The core offering consists of the Freespira hardware device (now in its fifth generation FST5) combined with a proprietary software application and coaching services. The system includes a compact breathing sensor, tablet with real-time feedback display, nasal cannula, and dedicated Care Specialist support. Treatment follows a 28-day protocol with twice-daily 17-minute sessions. After completing the program, patients receive the Freespira Tones App for continued practice. All components work together as an integrated at-home treatment solution that addresses the underlying physiological causes of anxiety disorders through breathing retraining.
Differentiator
Problem solved
Functional benefit
Products and services
- Freespira Digital Therapeutic System (FST5) FDA-cleared at-home medical device that combines a proprietary breathing sensor with an integrated display tablet to provide real-time, feedback-guided respiratory retraining for adults and adolescents with panic disorder and PTSD.
- Freespira 28-Day Treatment Protocol At-home treatment program requiring two 17-minute sessions per day for 28 days, using capnography-guided respiratory intervention (CGRI) to normalize breathing patterns and reduce or eliminate panic attacks and PTSD symptoms. Includes device kit, real-time biofeedback, virtual onboarding, and weekly Care Specialist check-ins. Indicated for adults and adolescents (ages 13+) with panic disorder or PTSD.
Quantifiable outcome
- Over 80% of patients experienced significant symptom reduction post-treatment (panic disorder and PTSD combined)
- +7 more outcomes
Companies that use Freespira, Inc.
Customer profileNamed customers6 records
Segments6 records
Ideal customer profiles4 records
Freespira, Inc. technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Freespira, Inc. partnerships and signals
Strategic signalPartnerships
Ten partnerships are on record, tiered core, secondary and minor.
- Brighton MarinecoreFreespira partnered with Brighton Marine, a nonprofit administering the US Family Health Plan (USFHP) for Southern New England, to make its FDA-cleared digital therapeutic for panic disorder and PTSD available to Brighton Marine Health Plan members. The treatment became available in November 2025, representing Brighton Marine's commitment to providing veterans and military families with innovative mental health treatments.
- WellCare of KentuckycoreWellCare of Kentucky (a Centene Medicaid plan) launched a pilot program with Freespira providing eligible Medicaid members access to at-home digital therapeutic treatment for panic disorder and PTSD. WellCare is the first health plan in Kentucky to partner with a digital therapeutic company specializing in mental health. Analytics estimate 12% of WellCare's 450,000 Kentucky Medicaid members could benefit.
- Point32HealthcorePoint32Health (parent of Harvard Pilgrim Health Care and Tufts Health Plan) selected Freespira as winner of its inaugural Innovation Challenge, recognizing it as a pioneering solution for mental health outcomes and affordability. The partnership aims to pilot Freespira's treatment technology to expand mental health options for Point32Health's 2.2 million members in New England.
- Highmark BCBScoreHighmark BCBS expanded access to Freespira's digital therapeutic for panic disorder and PTSD across its member base. A Highmark behavioral health director cited reduced medication use and healthcare cost savings as drivers for the partnership.
- Security Health PlansecondarySecurity Health Plan selected Freespira as a new benefit offering for members with panic disorder and PTSD, integrating it into their covered mental health treatments.
- Lovell Government ServicescoreFreespira is listed on the Federal Supply Schedule 65IIA #V797D-50450 through SDVOSB partner Lovell Government Services. Lovell facilitates VA procurement and handles the Government Services administration for Freespira's veteran treatment program. CAGE: 71G35, DUNS: 079230337, UEI: MNH3STM1FTS6.
- Crossover HealthsecondaryCrossover Health is listed as a Freespira partner, likely offering the treatment to its member population through employer-sponsored health benefits.
- Chorus PreferredsecondaryChorus Preferred is listed as a Freespira partner organization, potentially serving as a navigation platform or aggregator for the digital therapeutic.
- IMPACT (Virtual First Medical Practice Collaborative)minorFreespira is a founding member of IMPACT, the Virtual First Medical Practice Collaborative at the Digital Medicine Society, focused on advancing digital medicine and virtual-first care models.
- New Vista (Kentucky)minorNew Vista, a Kentucky-based organization specializing in integrated mental and physical healthcare, was designated as the key medical practice partner for WellCare of Kentucky's Freespira pilot program.
Scale indicators8 records
Recent moves6 records
Expansion highlights6 records
Freespira, Inc. competitors and assessment
Company assessmentDirect peers
- Big Health: Big Health develops FDA-cleared prescription digital therapeutics (Sleepio for insomnia, Daylight for anxiety) sold through health plans and employers on outcomes-based contracts. Most directly comparable to Freespira in PDT business model, payor go-to-market, and clinical evidence positioning.
- Akili Interactive: Akili markets EndeavorRx, an FDA-cleared prescription digital therapeutic (for ADHD) with similar payor reimbursement and clinical evidence strategy. Closest analog to Freespira among publicly known PDTs in regulatory pathway and business model.
- Pear Therapeutics: Pear Therapeutics pioneered FDA-cleared prescription digital therapeutics (reSET, reSET-O) for substance use disorder and is the historical reference point for Freespira's PDT model, though it filed for bankruptcy in 2023 illustrating category capital risks.
Emerging players
- Limbic: Limbic is a UK-based digital mental health platform offering AI-driven CBT and emotional support tools sold to health systems and payors. Comparable to Freespira as a technology-driven mental health intervention with payor channels, though focused on a different delivery modality.
- Woebot Health: Woebot Health delivers AI chatbot-based mental health interventions with FDA Breakthrough Device designation. Comparable to Freespira as an emerging digital therapeutic in behavioral health with regulatory clearance pursuit, though software-only and consumer-focused.
Broad incumbents
- Lyra Health: Lyra Health is a leading mental health benefits platform for employers, bundling therapy, coaching, and digital tools. Comparable to Freespira as a payor-facing mental health vendor, but operates as a broad incumbent across the full continuum of care rather than a single therapeutic.
- Spring Health: Spring Health provides employer-sponsored mental health benefits combining provider networks, coaching, and digital programs. Comparable to Freespira as a payor channel for anxiety/PTSD care, but offers a broader, integrated solution set rather than a single device-based treatment.
- Cerebral: Cerebral is a subscription-based mental health platform offering telehealth psychiatry and therapy for anxiety, depression, and related conditions. Comparable to Freespira in DTC marketing and anxiety-focused positioning, though broader in scope and provider-delivered.
- Talkspace: Talkspace operates an online therapy platform sold through health plans and employers. Comparable to Freespira as a payor-covered mental health service targeting anxiety and trauma-related conditions, though therapy-delivered rather than device-based.
- BetterHelp: BetterHelp (a Teladoc Health subsidiary) is the largest consumer-facing online therapy platform. Comparable to Freespira in serving patients with anxiety and PTSD symptoms via remote care, though broader in scope and pure-software in delivery.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
Freespira, Inc. social profiles
Digital presenceFreespira, Inc. compliance and trust
Trust signalCompliance2 records
Freespira, Inc. financial estimates
Financial estimateRevenue estimate
Valuation estimate
Freespira, Inc. leadership team
Management profileNumber of profiles
Profiles11 records
Freespira, Inc. funding detail
Funding detailFunding overview
Funding rounds7 records
Investors4 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Freespira, Inc. M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Freespira, Inc.
What does Freespira, Inc. do?
Freespira develops and sells an FDA-cleared at-home digital therapeutic that combines a proprietary breathing sensor, integrated tablet with real-time capnometry feedback software, and Care Specialist coaching to normalize dysfunctional breathing patterns and reduce or eliminate symptoms of panic attacks, panic disorder, and PTSD in a 28-day protocol. The bundled treatment kit is shipped directly to patients' homes and is covered as a medical benefit by health plans, self-insured employers, and the VA.
Is Freespira, Inc. a public or private company?
Freespira, Inc. is a private company. It is classified as venture growth investor backed and is currently operating.
When was Freespira, Inc. founded?
Freespira, Inc. was founded in 2013. It employs 11 to 50 people.
Where is Freespira, Inc. based?
Freespira, Inc. is headquartered in Kirkland, United States, in the North America region.
How does Freespira, Inc. make money?
Four revenue lines are on record. Health Plan and Employer Benefit Coverage is the primary driver. The others are VA Federal Procurement, self-Pay / HSA/FSA / Payment Plans and outcomes-Based / Performance Pricing.
Who are Freespira, Inc.'s main competitors?
Direct peers on record are Big Health, Akili Interactive and Pear Therapeutics. Emerging players are Limbic and Woebot Health. Broad incumbents are Lyra Health, Spring Health, Cerebral, Talkspace and BetterHelp.
Does Freespira, Inc. have an API?
No public API is recorded for Freespira, Inc..
What industry is Freespira, Inc. in?
Freespira, Inc.'s product category is Digital Therapeutics. Its primary akta.pro industry code is HLACAFAL, Connected Therapeutics & Smart Drug Delivery Monitoring, with a secondary code of HLALAFAF, Medication Adherence, Digital Therapeutics & Remote Coaching (condition-specific programs). Its NAICS code is 62161 and its SIC code is 8090.